Janus Henderson Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$178K Hold
39,469
﹤0.01% 2346
2025
Q4
$243K Hold
39,469
﹤0.01% 2289
2025
Q3
$285K Hold
39,469
﹤0.01% 2226
2025
Q2
$209K Hold
39,469
﹤0.01% 2305
2025
Q1
$350K Hold
39,469
﹤0.01% 2138
2024
Q4
$541K Hold
39,469
﹤0.01% 1996
2024
Q3
$1.08M Hold
39,469
﹤0.01% 1626
2024
Q2
$965K Sell
39,469
-408
-1% -$8.95K ﹤0.01% 1638
2024
Q1
$849K Buy
39,877
+1
+0% +$21 ﹤0.01% 1731
2023
Q4
$763K Sell
39,876
-60
-0.2% -$1.04K ﹤0.01% 1783
2023
Q3
$640K Buy
39,936
+6
+0% +$114 ﹤0.01% 1804
2023
Q2
$925K Sell
39,930
-41
-0.1% -$895 ﹤0.01% 1648
2023
Q1
$927K Buy
39,971
+24,682
+161% +$501K ﹤0.01% 1674
2022
Q4
$222K Sell
15,289
-15,291
-50% -$285K ﹤0.01% 2139
2022
Q3
$584K Buy
30,580
+15,305
+100% +$351K ﹤0.01% 1889
2022
Q2
$278K Sell
15,275
-11
-0.1% -$228 ﹤0.01% 2123
2022
Q1
$384K Buy
15,286
+13
+0.1% +$333 ﹤0.01% 2064
2021
Q4
$422K Buy
15,273
+7,682
+101% +$223K ﹤0.01% 1998
2021
Q3
$245K Buy
+7,591
New +$252K ﹤0.01% 1983

Other funds holding MYGN